Hyperoxaluria in L-Glyceric Aciduria: Possible Pathogenic Mechanism-Reference-Cited by-同舟云学术

Hyperoxaluria in L-Glyceric Aciduria: Possible Pathogenic Mechanism

Published:1971-01-29 Issue:3969 Volume:171 Page:390-391
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Williams Hibbard E.¹,Smith Lloyd H.¹

Affiliation:

1. Department of Medicine, University of California School of Medicine, San Francisco 94122

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference8 articles.

1. HOCKADAY, TDR, STUDIES ON PRIMARY HYPEROXALURIA .2. URINARY OXALATE GLYCOLATE AND GLYOXYLATE MEASUREMENT BY ISOTOPE DILUTION METHODS, JOURNAL OF LABORATORY AND CLINICAL MEDICINE 65: 677 (1965).

2. HOCKADAY, TDR, PRIMARY HYPEROXALURIA, MEDICINE 43: 315 (1964).

3. ROMANO, M, ACTION OF CRYSTALLINE LACTATE DEHYDROGENASE FROM RABBIT MUSCLE ON GLYOXYLATE, BIOCHIMICA ET BIOPHYSICA ACTA 177: 421 (1969).

4. SAWAKI, S, REDUCTION OF GLYOXYLATE BY LACTATE DEHYDROGENASE, JOURNAL OF VITAMINOLOGY 12: 210 (1966).

5. SUSSMAN, K.E., CHRONIC LACTIC ACIDOSIS IN AN ADULT - A NEW SYNDROME ASSOCIATED WITH AN ALTERED REDOX STATE OF CERTAIN NAD/NADH COUPLED REACTIONS, AMERICAN JOURNAL OF MEDICINE 48: 104 (1970).

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nedosiran population pharmacokinetic and pharmacodynamic modelling and simulation to guide clinical development and dose selection in patients with primary hyperoxaluria type 1;British Journal of Clinical Pharmacology;2024-08-07

2. Safety, Pharmacokinetics, and Exposure–Response Modeling of Nedosiran in Participants With Severe Chronic Kidney Disease;Clinical Pharmacology in Drug Development;2023-08-21

3. Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria;Kidney International;2021-09

4. Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria;Kidney International Reports;2021-04

5. Nephrolithiasis in Chronic Kidney Disease;Nutritional and Medical Management of Kidney Stones;2019